Skip to main content
SpringerLink
Log in

Introduction to Radionuclide Therapy

  • Chapter
Targeted Radionuclide Tumor Therapy

Summary

This introductory chapter is written for those who are new to the field and desire a short overview of the present status of clinical and preclinical radionuclide therapy. In particular, this chapter provides an overview of the radiophysical concepts and key aspects of dosimetry and treatment planning that are beyond the scope of this book’s focus on biological aspects of radionuclide therapy. Finally, a discussion on the choice of radionuclides and the availability of radiopharmaceuticals is provided.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Witzig TE (2006) Radioimmunotherapy for B-cell non-Hodgkin lymphoma. Best Pract Res Clin Haematol 19(4):655-68. Review.

    Article  PubMed  Google Scholar 

  2. Adams GP, Weiner LM (2005) Monoclonal antibody therapy of cancer. Nat Biotechnol 23(9):1147-57. Review.

    Article  PubMed  Google Scholar 

  3. Goldenberg DM, Sharkey RM (2006) Advances in cancer therapy with radiolabeled monoclonal antibodies. Q J Nucl Med Mol Imaging 50(4):248-64. Review.

    PubMed  Google Scholar 

  4. DeNardo SJ, DeNardo GL (2006) Targeted radionuclide therapy for solid tumors: an overview. Int J Radiat Oncol Biol Phys 66(2 Suppl):S89-95. Review.

    PubMed  Google Scholar 

  5. Oyen WJ, Bodei L, Giammarile F, Maecke HR, Tennvall J, Luster M, Brans B (2007) Targeted therapy in nuclear medicine-current status and future prospects. Ann Oncol 18(11):1782-92. Review.

    Article  PubMed  Google Scholar 

  6. Boerman OC, Koppe MJ, Postema EJ, Corstens FH, Oyen WJ (2007) Radionuclide therapy of cancer with radiolabeled antibodies. Anticancer Agents Med Chem 7(3):335-43. Review.

    Article  PubMed  Google Scholar 

  7. Pacini F, Schlumberger M, Harmer C, Berg GG, Cohen O, Duntas L, Jamar F, Jarzab B, Limbert E, Lind P, Reiners C, Sanchez Franco F, Smit J, Wiersinga W (2005) Post-surgical use of radioiodine 131I in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report. Eur J Endocrinol 153:651-9.

    Article  PubMed  Google Scholar 

  8. Woodrum DT, Gauger PG (2005) Role of 131I in the treatment of well differentiated thyroid cancer. J Surg Oncol 89:114-21.

    Article  PubMed  Google Scholar 

  9. Berlin NI (2000) Treatment of the myeloproliferative disorders with 32P. Eur J Haematol 65(1):1-7. Review.

    Article  PubMed  Google Scholar 

  10. Berlin NI (2002) Polycythemia vera: diagnosis and treatment 2002. Expert Rev Anticancer Ther 2(3):330-6. Review.

    Article  PubMed  Google Scholar 

  11. Davis TA, Kaminski MS, Leonard JP, Hsu FJ, Wilkinson M, Zelenetz A, Wahl RL, Kroll S, Coleman M, Goris M, Levy R, Knox SJ (2004) The radioisotope contributes significantly to the activity of radioimmunotherapy. Clin Cancer Res 10:7792-7798.

    Article  PubMed  Google Scholar 

  12. Chrisoulidou A, Kaltsas G, Ilias I, Grossman AB (2007) The diagnosis and management of malignant phaeochromocytoma and paraganglioma. Endocr Relat Cancer 14(3):569-85. Review.

    Article  PubMed  Google Scholar 

  13. Howman-Giles R, Shaw PJ, Uren RF, Chung DK (2007) Neuroblastoma and other neuroendocrine tumors. Semin Nucl Med 37(4):286-302. Review.

    Article  PubMed  Google Scholar 

  14. Scholz T, Eisenhofer G, Pacak K, Dralle H, Lehnert H (2007) Clinical review: current treatment of malignant pheochromocytoma. J Clin Endocrinol Metab 92(4):1217-25. Review.

    Article  PubMed  Google Scholar 

  15. Kwekkeboom DJ, Mueller-Brand J, Paganelli G, Anthony LB, Pauwels S, Kvols LK, O’dorisio TM, Valkema R, Bodei L, Chinol M, Maecke HR, Krenning EP (2005) Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs. J Nucl Med 46(Suppl 1):62S-66S.

    PubMed  Google Scholar 

  16. Forrer F, Valkema R, Kwekkeboom DJ, de Jong M, Krenning EP (2007) Peptide receptor radionuclide therapy. Best Pract Res Clin Endocrinol Metab 21:111-29.

    Article  PubMed  Google Scholar 

  17. Van Essen M, Krenning EP, De Jong M, Valkema R, Kwekkeboom DJ (2007) Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours. Acta Oncol 46(6):723-34. Review.

    Article  PubMed  Google Scholar 

  18. Finlay IG, Mason MD, Shelley M (2005) Radioisotopes for the palliation of metastatic bone cancer: a systematic review. Lancet Oncol 6:392-400.

    Article  PubMed  Google Scholar 

  19. Bauman G, Charette M, Reid R, Sathya J (2005) Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review. Radiother Oncol 75:258-270.

    PubMed  Google Scholar 

  20. Lawrentschuk N, Davis ID, Bolton DM, Scott AM (2007) Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: current practice. Int J Urol 14:89-95.

    Article  PubMed  Google Scholar 

  21. Press OW, Eary JF, Gooley T, Gopal AK, Liu S, Rajendran JG, Maloney DG, Petersdorf S, Bush SA, Durack LD, Martin PJ, Fisher DR, Wood B, Borrow JW, Porter B, Smith JP, Matthews DC, Appelbaum FR, Bernstein ID (2000) A phase I/II trial of iodine-131 tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas. Blood 96:2934-42.

    PubMed  Google Scholar 

  22. Molina A, Krishnan A, Fung H, Flinn IW, Inwards D, Winter JN, Nademanee A (2007) Use of radioimmunotherapy in stem cell transplantation and posttransplantation: focus on yttrium 90 ibritumomab tiuxetan. Curr Stem Cell Res Ther 2(3):239-48. Review.

    Article  PubMed  Google Scholar 

  23. Buchsbaum DJ (2000) Experimental radioimmunotherapy. Semin Radiat Oncol 10 (2):156-67.

    Article  PubMed  Google Scholar 

  24. Behr TM, Blumenthal RD, Memtsoudis S, et al. (2000) Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments. Clin Cancer Res 6 (12):4900-7.

    PubMed  Google Scholar 

  25. Barendswaard EC, Humm JL, O’Donoghue JA, et al. (2001) Relative therapeutic efficacy of (125)I- and (131)I-labeled monoclonal antibody A33 in a human colon cancer xenograft. J Nucl Med 42(8):1251-6.

    PubMed  Google Scholar 

  26. de Jong M, Breeman WAP, Bernard BF, et al. (2001) [177Lu-DOTA0, Tyr3]octreotate for somatostatin receptor-targeted radionuclide therapy. Int J Cancer 92:628-33.

    Article  PubMed  Google Scholar 

  27. Kassis AI, Adelstein SJ (2005) Radiobiologic principles in radionuclide therapy. J Nucl Med 46(Suppl 1):4-12. Review.

    Google Scholar 

  28. Murray D, McEwan AJ (2007) Radiobiology of systemic radiation therapy. Cancer Biother Radiopharm 22(1):1-23. Review.

    Article  PubMed  Google Scholar 

  29. O’Donoghue JA, Bardies M, Wheldon TE (1995) Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides. J Nucl Med 36 (10):1902-09.

    PubMed  Google Scholar 

  30. Hartman T, Lundqvist H, Westlin JE, Carlsson J (2000) Radiation doses to the cell nucleus in single cells and cells in micrometastases in targeted therapy with 131I labelled ligands or antibodies. Int J Radiat Oncol Biol Phys 46(4):1025-1036.

    PubMed  Google Scholar 

  31. de Jong M, Breeman WA, Valkema R, Bernard BF, Krenning EP (2005) Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs. J Nucl Med 46(Suppl 1):13S-7S.

    PubMed  Google Scholar 

  32. Bernhardt P, Forssell-Aronsson E, Jacobsson L, Skarnemark G (2001) Low-energy electron emitters for targeted radiotherapy of small tumours. Acta Oncol 40(5):602-8.

    Article  PubMed  Google Scholar 

  33. Wessels BW, Syh JH, Meredith RF (2006) Overview of dosimetry for Systemic Targeted Radionuclide Therapy (STaRT). Int J Radiat Oncol Biol Phys 66(2 Suppl):S39-45. Review.

    PubMed  Google Scholar 

  34. Ell PJ, Gambhir S (2004) Nuclear Medicine in Clinical Diagnosis and Treatment. Elsevier Health Sciences, Edinburgh, UK (ISBN: 9780443073120).

    Google Scholar 

  35. Ramer K, Alavi A (2005) Nuclear Medicine Technology. Springer, New York (ISBN: 3540253742).

    Google Scholar 

  36. Schiepers C (2005) Diagnostic Nuclear Medicine. Springer, Germany (ISBN: 9783540423096).

    Google Scholar 

  37. Zaidi H (2005) Quantitative Analysis in Nuclear Medicine Imaging. Springer, New York (ISBN: 9780387238548).

    Google Scholar 

  38. Saha GB (2006) Physics and Radiobiology of Nuclear Medicine. Springer, New York (ISBN: 9780387307541).

    Google Scholar 

  39. Christian PE, Waterstram-Rich K (2007) Nuclear Medicine and Pet/Ct Technology and Techniques. Elsevier Health Sciences, St. Louis, MO (ISBN: 9780323043953).

    Google Scholar 

  40. Morton KA, Nance RW, Clark PB, Christensen CR, O’Malley JP, Blodgett TM, Waxman AD, Stevens JS, Drosten R, Chinn CA (2007) Nuclear Medicine. W.B. Saunders, Edinburgh, UK (ISBN: 9781416033394).

    Google Scholar 

  41. Evans ES, Hahn CA, Kocak Z, Zhou SM, Marks LB (2007) The role of functional imaging in the diagnosis and management of late normal tissue injury. Semin Radiat Oncol 17(2):72-80. Review.

    Article  PubMed  Google Scholar 

  42. Saleem A, Charnley N, Price P (2006) Clinical molecular imaging with positron emission tomography. Eur J Cancer 42(12):1720-7. Review.

    Article  PubMed  Google Scholar 

  43. Brans B, Bodei L, Giammarile F, Linden O, Luster M, Oyen WJ, Tennvall J (2007) Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”. Eur J Nucl Med Mol Imaging 34 (5):772-86. Review.

    Article  PubMed  Google Scholar 

  44. Thomas SR (2007) From the SNM MIRD committee. J Nucl Med 48(2):33N-34N.

    Google Scholar 

  45. Carlsson J, Forssell AE, Hietala SO, Stigbrand T, Tennvall J (2003) Tumour therapy with radionuclides; assessment of progress and problems. Radiother Oncol 66(2):107-17.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unit of Biomedical Radiation Sciences, Department of Oncology, Radiology and Clinical Immunology, Rudbeck Laboratory, Uppsala University, SE-751 85, Uppsala, Sweden

    Jörgen Carlsson

  2. Department of Immunology, Clinical Microbiology, University of Umeå, SE-90185, Umeå, Sweden

    Torgny Stigbrand

  3. Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA

    Gregory P. Adams

Authors
  1. Jörgen Carlsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Torgny Stigbrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gregory P. Adams
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Immunology, University of Umea, Umea, Sweden

    Torgny Stigbrand

  2. Rudbeck Laboratory, Uppsala University, Uppsala, Sweden

    Jörgen Carlsson

  3. Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, USA

    Gregory P. Adams

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science + Business Media B.V

About this chapter

Cite this chapter

Carlsson, J., Stigbrand, T., Adams, G.P. (2008). Introduction to Radionuclide Therapy. In: Stigbrand, T., Carlsson, J., Adams, G.P. (eds) Targeted Radionuclide Tumor Therapy. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-8696-0_1

Download citation

Publish with us

Policies and ethics

Search

Navigation